The expanded approval was based on data from a phase 3 study that compared Flucelvax Quadrivalent to a US-licensed comparator quadrivalent influenza vaccine.
Investigators assessed the factors associated with medication treatment for opioid use disorder and whether it is linked to hepatic decompensation or death in patients with cirrhosis and active opioid use disorder.
In a virtual plenary poster presented at ASBMR 2021, study authors determined the association between vitamin D status and COVID-19 severity and mortality, as well as the risk for SARS-CoV-2 infection and hospitalization.
Researchers sought to identify the symptoms that are likely to occur among pediatric patients with SARS-CoV-2 infection detected via polymerase chain reaction testing.
The submission is based on data from the phase 3 MOVe-OUT trial, which evaluated molnupiravir in 775 nonhospitalized adults with mild to moderate COVID-19.
The natural history of cirrhosis is significantly affected by the increasing prevalence of infections, with strategies for prevention and treatment difficult to compose.
Study finds that among women with uncomplicated urinary tract infection (UTI), those with antimicrobial-resistant isolates are at increased risk for progression to complicated UTI vs those with susceptible isolates.
Researchers conducted a study that compared the prevalence of COVID-19 with influenza co-infection among the general population vs hospitalized patients, as well as outcomes associated with both infections vs COVID-19 alone.
Researchers summarized the reciprocal interaction between sleep and liver diseases, including cirrhosis, and investigated potential approaches for therapeutic interventions.
